Variables | Pre-treatment | Post-treatment | ||||
---|---|---|---|---|---|---|
% positive (no. pos./no exam) | GMEPG | % positive (no. pos./no exam) | GMEPG | % reduction in prevalence | % reduction in GMEPG | |
Age groups | ||||||
6–9 years | 80.9 (85/105) | 421.8 | 13.8 (11/80) | 77.79 | 87.1 | 81.4 |
10–14 years | 85.5 (118/138) | 303.34 | 11.6 (11/95) | 74.3 | 90.7 | 70.8 |
≥ 15 years | 50 (1/2) | 360 | 100 (1) | 120 | 0 | 66.7 |
χ2 (p) | 2.89 (0.193) | 4.59 (0.17) | 17.3 (0.33) | |||
Sex | ||||||
Male | 83.1 (138/166) | 415.06 | 12.1(14/116) | 102 | 89.6 | 75.4 |
Female | 83.5 (66/79) | 284.03 | 15 (9/60) | 51 | 86.4 | 80.1 |
χ2 (p) | 0.007 (0.936) | 5.92 (0.67) | 5.92 (0.67) |